- Library Home
- Browse Items
- Browse Collections
- Commentary and List Archive
- PedPalASCNET Home
Focus on paroxetine
Focus on paroxetine
Current Medical Research And Opinion
Humans; Treatment Outcome; Drug Interactions; Animals; Antidepressive Agents; Stress Disorders; Anxiety Disorders/drug therapy; Depression/drug therapy; Paroxetine/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Post-Traumatic/drug therapy; Second-Generation/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Serotonin Uptake Inhibitors/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Substance Withdrawal Syndrome
This review of paroxetine is based on Medline and PsycLit searches and a manual search of the available research literature. It aims to cover the pharmacology of this frequently prescribed SSRI antidepressant in terms of its indications, efficacy and adverse effects. Overall, paroxetine is a well-tolerated and safe first-line SSRI antidepressant with anxiolytic qualities. It has been found useful in depression, anxiety and other conditions such as obsessive compulsive disorder and post-traumatic stress disorder. The antidepressant has some advantages over earlier tricyclic medication in terms of a lack of cardiovascular side-effects and relative safety in overdose. Cessation of use, however, is associated with withdrawal or discontinuation symptoms and patients should be counselled as to how these might be avoided. A 3- or 4-week graded withdrawal regimen, perhaps with concomitant fluoxetine to cover serotonergic discontinuation symptoms, may be advisable.
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Citation List Month
Green B, “Focus on paroxetine,” Pediatric Palliative Care Library, accessed January 19, 2022, https://pedpalascnetlibrary.omeka.net/items/show/12709.